OEA alleviates apoptosis in diabetic rats with myocardial ischemia/reperfusion injury by regulating the PI3K/Akt signaling pathway through activation of TRPV1

Reperfusion therapy after myocardial infarction may lead to myocardial injury, which can be complicated and exacerbated by diabetes. The existing therapeutic methods for myocardial ischemia-reperfusion injury (MIRI) in diabetic patients are not ideal. Oleoylethanolamide (OEA) has been found to have...

Full description

Bibliographic Details
Main Authors: Enhui Yao, Lili Luo, Chenxi Lin, Jing Wen, Yanglongfei Li, Tong Ren, Yujie Chen, Jinhua Huang, Xin Jin
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.964475/full
_version_ 1811225010783649792
author Enhui Yao
Lili Luo
Chenxi Lin
Jing Wen
Yanglongfei Li
Tong Ren
Yujie Chen
Jinhua Huang
Xin Jin
author_facet Enhui Yao
Lili Luo
Chenxi Lin
Jing Wen
Yanglongfei Li
Tong Ren
Yujie Chen
Jinhua Huang
Xin Jin
author_sort Enhui Yao
collection DOAJ
description Reperfusion therapy after myocardial infarction may lead to myocardial injury, which can be complicated and exacerbated by diabetes. The existing therapeutic methods for myocardial ischemia-reperfusion injury (MIRI) in diabetic patients are not ideal. Oleoylethanolamide (OEA) has been found to have protective effects on diabetes and acute cerebral ischemia. This study aimed to determine whether OEA can alleviate MIRI in diabetic rats, and to explore the underlying mechanism. The model of diabetic rats with MIRI was established by blocking the left coronary artery for 30 min, followed by restoring blood flow stability for 120 min. The myocardial enzyme spectrum, area of MIRI, and expression levels of apoptosis-related proteins were detected. The results showed that OEA pretreatment could reduce myocardial infarction area, protect myocardial tissue structure, and reduce myocardial cell apoptosis in diabetic rats with MIRI. Meanwhile, the levels of creatine kinase (CK)-MB (CK-MB), lactate dehydrogenase (LDH), and malondialdehyde (MDA) were reduced, while superoxide dismutase (SOD) level was elevated. H9C2 cells were treated with high glucose and oxygen-glucose deprivation/reperfusion (OGD/R) to establish an in vitro model. Capsazepine (CPZ), an antagonist of transient receptor potential vanilloid subtype 1 (TRPV1), and LY294002, an inhibitor of PI3K, were used to treat H9C2 cells in vitro. Apoptosis level and the expression levels of apoptosis-related proteins were measured. It was found that OEA activated TRPV1 and the PI3K/Akt signaling pathway, downregulated the expression levels of apoptosis-related proteins (Bcl-2 and cleaved caspase-3), and ameliorated the apoptosis of H9C2 cells treated with high glucose and OGD/R. This study clarified that OEA, as a TRPV1 agonist, could reduce myocardial cell apoptosis by activating the PI3K/Akt signaling pathway in diabetic rats with MIRI. The findings may provide a theoretical basis for administration of OEA as a potential therapeutic agent into diabetic patients with MIRI.
first_indexed 2024-04-12T08:58:39Z
format Article
id doaj.art-cb4bc8c249d84e238ec057998fdf3467
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-12T08:58:39Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-cb4bc8c249d84e238ec057998fdf34672022-12-22T03:39:19ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-11-011310.3389/fphar.2022.964475964475OEA alleviates apoptosis in diabetic rats with myocardial ischemia/reperfusion injury by regulating the PI3K/Akt signaling pathway through activation of TRPV1Enhui Yao0Lili Luo1Chenxi Lin2Jing Wen3Yanglongfei Li4Tong Ren5Yujie Chen6Jinhua Huang7Xin Jin8Department of Cardiology, Fujian Medical University Union Hospital, Fujian Institute of Coronary Artery Disease, Fujian Heart Medical Center, Fuzhou, ChinaXiamen Key Laboratory of Chiral Drugs, School of Medicine, Xiamen University, Xiamen, ChinaDepartment of Pediatrics, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, ChinaXiamen Key Laboratory of Chiral Drugs, School of Medicine, Xiamen University, Xiamen, ChinaDepartment of Cardiology, Fujian Medical University Union Hospital, Fujian Institute of Coronary Artery Disease, Fujian Heart Medical Center, Fuzhou, ChinaXiamen Key Laboratory of Chiral Drugs, School of Medicine, Xiamen University, Xiamen, ChinaDepartment of Cardiology, Fujian Medical University Union Hospital, Fujian Institute of Coronary Artery Disease, Fujian Heart Medical Center, Fuzhou, ChinaDepartment of Cardiology, Fujian Medical University Union Hospital, Fujian Institute of Coronary Artery Disease, Fujian Heart Medical Center, Fuzhou, ChinaXiamen Key Laboratory of Chiral Drugs, School of Medicine, Xiamen University, Xiamen, ChinaReperfusion therapy after myocardial infarction may lead to myocardial injury, which can be complicated and exacerbated by diabetes. The existing therapeutic methods for myocardial ischemia-reperfusion injury (MIRI) in diabetic patients are not ideal. Oleoylethanolamide (OEA) has been found to have protective effects on diabetes and acute cerebral ischemia. This study aimed to determine whether OEA can alleviate MIRI in diabetic rats, and to explore the underlying mechanism. The model of diabetic rats with MIRI was established by blocking the left coronary artery for 30 min, followed by restoring blood flow stability for 120 min. The myocardial enzyme spectrum, area of MIRI, and expression levels of apoptosis-related proteins were detected. The results showed that OEA pretreatment could reduce myocardial infarction area, protect myocardial tissue structure, and reduce myocardial cell apoptosis in diabetic rats with MIRI. Meanwhile, the levels of creatine kinase (CK)-MB (CK-MB), lactate dehydrogenase (LDH), and malondialdehyde (MDA) were reduced, while superoxide dismutase (SOD) level was elevated. H9C2 cells were treated with high glucose and oxygen-glucose deprivation/reperfusion (OGD/R) to establish an in vitro model. Capsazepine (CPZ), an antagonist of transient receptor potential vanilloid subtype 1 (TRPV1), and LY294002, an inhibitor of PI3K, were used to treat H9C2 cells in vitro. Apoptosis level and the expression levels of apoptosis-related proteins were measured. It was found that OEA activated TRPV1 and the PI3K/Akt signaling pathway, downregulated the expression levels of apoptosis-related proteins (Bcl-2 and cleaved caspase-3), and ameliorated the apoptosis of H9C2 cells treated with high glucose and OGD/R. This study clarified that OEA, as a TRPV1 agonist, could reduce myocardial cell apoptosis by activating the PI3K/Akt signaling pathway in diabetic rats with MIRI. The findings may provide a theoretical basis for administration of OEA as a potential therapeutic agent into diabetic patients with MIRI.https://www.frontiersin.org/articles/10.3389/fphar.2022.964475/fulloleoylethanolamidemyocardial ischemia-reperfusion injurydiabetic ratsapoptosisTRPV1
spellingShingle Enhui Yao
Lili Luo
Chenxi Lin
Jing Wen
Yanglongfei Li
Tong Ren
Yujie Chen
Jinhua Huang
Xin Jin
OEA alleviates apoptosis in diabetic rats with myocardial ischemia/reperfusion injury by regulating the PI3K/Akt signaling pathway through activation of TRPV1
Frontiers in Pharmacology
oleoylethanolamide
myocardial ischemia-reperfusion injury
diabetic rats
apoptosis
TRPV1
title OEA alleviates apoptosis in diabetic rats with myocardial ischemia/reperfusion injury by regulating the PI3K/Akt signaling pathway through activation of TRPV1
title_full OEA alleviates apoptosis in diabetic rats with myocardial ischemia/reperfusion injury by regulating the PI3K/Akt signaling pathway through activation of TRPV1
title_fullStr OEA alleviates apoptosis in diabetic rats with myocardial ischemia/reperfusion injury by regulating the PI3K/Akt signaling pathway through activation of TRPV1
title_full_unstemmed OEA alleviates apoptosis in diabetic rats with myocardial ischemia/reperfusion injury by regulating the PI3K/Akt signaling pathway through activation of TRPV1
title_short OEA alleviates apoptosis in diabetic rats with myocardial ischemia/reperfusion injury by regulating the PI3K/Akt signaling pathway through activation of TRPV1
title_sort oea alleviates apoptosis in diabetic rats with myocardial ischemia reperfusion injury by regulating the pi3k akt signaling pathway through activation of trpv1
topic oleoylethanolamide
myocardial ischemia-reperfusion injury
diabetic rats
apoptosis
TRPV1
url https://www.frontiersin.org/articles/10.3389/fphar.2022.964475/full
work_keys_str_mv AT enhuiyao oeaalleviatesapoptosisindiabeticratswithmyocardialischemiareperfusioninjurybyregulatingthepi3kaktsignalingpathwaythroughactivationoftrpv1
AT lililuo oeaalleviatesapoptosisindiabeticratswithmyocardialischemiareperfusioninjurybyregulatingthepi3kaktsignalingpathwaythroughactivationoftrpv1
AT chenxilin oeaalleviatesapoptosisindiabeticratswithmyocardialischemiareperfusioninjurybyregulatingthepi3kaktsignalingpathwaythroughactivationoftrpv1
AT jingwen oeaalleviatesapoptosisindiabeticratswithmyocardialischemiareperfusioninjurybyregulatingthepi3kaktsignalingpathwaythroughactivationoftrpv1
AT yanglongfeili oeaalleviatesapoptosisindiabeticratswithmyocardialischemiareperfusioninjurybyregulatingthepi3kaktsignalingpathwaythroughactivationoftrpv1
AT tongren oeaalleviatesapoptosisindiabeticratswithmyocardialischemiareperfusioninjurybyregulatingthepi3kaktsignalingpathwaythroughactivationoftrpv1
AT yujiechen oeaalleviatesapoptosisindiabeticratswithmyocardialischemiareperfusioninjurybyregulatingthepi3kaktsignalingpathwaythroughactivationoftrpv1
AT jinhuahuang oeaalleviatesapoptosisindiabeticratswithmyocardialischemiareperfusioninjurybyregulatingthepi3kaktsignalingpathwaythroughactivationoftrpv1
AT xinjin oeaalleviatesapoptosisindiabeticratswithmyocardialischemiareperfusioninjurybyregulatingthepi3kaktsignalingpathwaythroughactivationoftrpv1